AACR22: As post-Covid development takes shape, BioNTech reports first human data for CAR-T/cancer vaccine combo - Endpoints News

NEW ORLEANS — Continuing to push into new frontiers following the huge success of its Covid-19 vaccine, BioNTech revealed the first-in-human data for its combination CAR-T and mRNA cancer therapy. In a Phase I portion of a Phase I/II study, the German biotech…

Amgen wants to know who’s in? For Enbrel, that is, in a new campaign focused on the future for people with rheumatoid arthritis and psoriatic arthritis who say in TV ads: “I’m in for what’s next.” T… [+604 chars]

full article...